| Expediting and lowering the cost of the drug development process | www.genicell.co Angelist Profile
Summary• Costs ~$1 Billion to bring a single drug to market.• 98% of novel compounds fail preclinical test stage.• Genicell technology provides 3 major benefits: – Reduces the amount of time necessary to bring a drug to market – Lowers the cost of drug discovery/testing – Reduces the number of animals used during drug development
Pain• Pharmaceutical companies are researching alternative ways to evaluate novel compounds to compensate for the increasing prices of typical go-to-market strategies.• Typical time to market for new drug is 10-12 years and costs close to $1 Billion• We can funnel out the compounds that will fail the preclinical testing stage before they enter these expensive trials.
Genicell Technology Intellectual Property Potential • Novel bioreactor (provision filed 3/2012) • Cells used to create construct • Protocol for using system and testing drugs
Market and Customer Segments1. Pharmaceutical Companies/Contract Research Organizations (CROs)2. Small molecule companies3. Researchers in Academia
Go-to-market Strategy• Sell bioreactor technology to researchers and CROs• Market Genicell BBB testing to small molecule companies as an addition to their available testing suite• Following side-by-side testing of data gathered in our system vs. data collected from animals, we would be able to fully insert ourselves into the drug discovery pipeline for pharmaceutical companies